HSBC Holdings’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
HSBC Holdings's AMLX Position: Q3 2026 in Review
HSBC Holdings increased its Amylyx Pharmaceuticals (AMLX) stake by 126% in Q3 2026, buying an estimated $487K and bringing the position to 32,920 shares worth $958K. The position accounts for ﹤0.01% of the portfolio, ranked #1963.
HSBC Holdings first reported a position in AMLX in Q1 2024 and has held it in 9 quarters since. 230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- HSBC Holdings held 32,920 shares of Amylyx Pharmaceuticals worth $958K as of Q3 2026.
- HSBC Holdings bought 18,366 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $487K.
- Amylyx Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q3 2026, its #1963 holding.
- HSBC Holdings first reported a position in Amylyx Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
- 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.